Iowa Senate Bill SSB1017

Iowa 2025-2026 Regular Session

• Introduced: 1/16/25
• Refer: 1/16/25

Caption

A bill for an act relating to pharmacy benefits manager reverse auctions and group insurance for public employees.(See SF 315.)

Impact

The impact of SSB1017 on state laws primarily involves the administration of public employee health benefit plans under Iowa’s Code Chapter 509A. It mandates a shift in how state and local entities procure PBM services, requiring them to use an automated auction process that fosters competitive pricing. This shift could lead to substantial savings and better oversight of drug-related expenditures, but it may also necessitate updates to existing administrative frameworks to accommodate the new procedures outlined in the bill.

Summary

Senate Study Bill 1017 (SSB1017) introduces a structured process for conducting reverse auctions for pharmacy benefits managers (PBMs) that will serve public employee health plans in Iowa. The bill establishes new definitions and terms surrounding the bidding process, aiming to enhance cost efficiency and transparency in selecting PBMs who manage prescription drug benefits. This competitive online auction process is anticipated to enable public entities to procure PBM services at potentially lower costs due to the increased level of competition among bidders.

Contention

Notable points of contention surrounding SSB1017 involve discussions about its implications for existing relationships between state entities and current PBMs. While supporters argue that the bill will introduce much-needed competition and control costs, critics raise concerns about the potential disruptions this could cause for services currently in place. The transition to a reverse auction model may face pushback from established PBMs who might be apprehensive about increased scrutiny and the necessity to participate in a competitive bidding process.